Latest Whitepapers
Whitepaper
Quantitative Proteomics Services To Upgrade Your Research
Proteomics provides crucial insights into cell signaling and disease mechanisms for biomedical and clinical research. Nevertheless, traditional LC-MS/MS methods have limitations in sensitivity, reproducibility and scalability within proteomics applications.
Whitepaper
The Latest in Data Integrity Best Practices
This whitepaper explores the importance of data integrity in drug manufacturing workflows, so you stay up to date with the latest regulations.
Whitepaper
Purifying Next-Generation Biologics With Antibody-Based Selectivity
This whitepaper explores how antibody-based affinity chromatography can reduce the number of process steps, improve yield and increase the purity of your biologic products.
Whitepaper
A Guide to Cell Culture Success
Cell culture is essential for a variety of applications including disease modeling, drug discovery, cell-based manufacturing and genetic engineering.
Whitepaper
How To Accelerate and De-Risk Drug Development in Oncology
Although there are initiatives to de-risk the drug development process, continually applying the same tools and approaches is unlikely to lead to innovative, first- or best-in-class targets and transformative progress.
Whitepaper
The Rise of Tech Bio: Powering Life Science Innovation
Amidst the life science industry’s digital transformation, new and established companies have pioneered innovative ways to harness data and technology across the drug development lifecycle.
Whitepaper
The End of End-Point Assays
This whitepaper highlights the recent developments and performance of three modular benchtop solutions for the high-performance quantitation and kinetics characterization of proteins and their small molecule interactions.
Whitepaper
Streamlining Affinity Analysis for Accelerated Drug Discovery
This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening.
Whitepaper
Diving Deep Into Cell Therapy: An Industry Perspective
Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Whitepaper
Solid Form Informatics for Pharmaceuticals and Fine Chemicals
Solid form informatics (SFI) provides a knowledge-based approach to improve the effectiveness and quality of early-phase drug discovery research, as well as a rational approach to risk assessment.
Advertisement